Actively Recruiting
Transcranial Photobiomodulation in Anxiety Disorders
Led by Francisco Gonzalez-Lima, PhD · Updated on 2026-05-14
280
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The investigators have previously shown that safe, non-invasive methods of brain stimulation such as the administration of transcranial infrared light can result in improvements to cognition and emotion. The investigators hypothesize that transcranial photobiomodulation (tPBM) can be used in conjunction with attention bias assessment and modification to reduce anxiety symptoms in individuals with sub-clinical anxiety.
CONDITIONS
Official Title
Transcranial Photobiomodulation in Anxiety Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- 18 years of age and older
- State-Trait Anxiety Index (STAI) score between 40-59 indicating moderate sub-clinical anxiety
- Patient Health Questionnaire (PHQ-9) score between 1-9 indicating minimal to mild sub-clinical depression
You will not qualify if you...
- STAI score less than 40 or greater than 59
- PHQ-9 score greater than 9
- Medication change within 6 weeks before the study
- Indicated suicidal ideation
- Currently receiving transcranial photobiomodulation treatment
- Current pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The University of Texas at Austin
Austin, Texas, United States, 78712
Actively Recruiting
Research Team
F
Francisco Gonzalez-Lima, Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here